Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29;21(9):477.
doi: 10.3390/md21090477.

The Preventive Mechanism of Anserine on Tert-Butyl Hydroperoxide-Induced Liver Injury in L-02 Cells via Regulating the Keap1-Nrf2 and JNK-Caspase-3 Signaling Pathways

Affiliations

The Preventive Mechanism of Anserine on Tert-Butyl Hydroperoxide-Induced Liver Injury in L-02 Cells via Regulating the Keap1-Nrf2 and JNK-Caspase-3 Signaling Pathways

Ming Chen et al. Mar Drugs. .

Abstract

Anserine is a naturally occurring histidine dipeptide with significant antioxidant activities. This study aimed to investigate the preventive mechanism of anserine on tert-butyl hydroperoxide (TBHP)-induced liver damage in a normal human liver cell line (L-02 cells). The L-02 cells were pretreated with anserine (10, 20, and 40 mmol/L) and then induced with 400 μmol/L of TBHP for 4 h. The results showed that the survival rates of L-02 cells and the contents of GSH were significantly increased with the pretreatment of anserine; the activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the extracellular fluid were sharply decreased; and the formation of reactive oxygen species (ROS), nuclear fragmentation, and apoptosis were significantly inhibited. In addition, anserine could bind to the Kelch domain of Kelch-like ECH-associated protein 1 (Keap1) with a binding force of -7.2 kcal/mol; the protein expressions of nuclear factor-erythroid 2-related factor-2 (Nrf2), quinone oxidoreductase 1 (NQO1), heme oxygenase-1 (HO-1), and Bcl-2 were upregulated by anserine in TBHP-induced L-02 cells, with the downregulation of p-JNK and caspase-3. In conclusion, anserine might alleviated liver injury in L-02 cells via regulating related proteins in the Keap1-Nrf2 and JNK-Caspase-3 signaling pathways.

Keywords: JNK-Caspase-3; Keap1-Nrf2; L-02 cell; anrerine; apoptosis; liver injury; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of anserine.
Figure 2
Figure 2
The effect of anserine on the survival rate of L-02 cells (A) and the survival rate of TBHP-induced L-02 cells (B). Data are displayed as the mean ± SD (n = 3). ## p < 0.01 compared with the control group; * p < 0.05, ** p < 0.01 compared with the model group.
Figure 3
Figure 3
Effect of anserine on ALT, AST, ROS, GSH, and the nucleus. (A) ALT, (B) AST, (C) ROS, and (D) GSH. Data are displayed as mean ± SD (n = 3). ## p < 0.01 compared with the control group; * p < 0.05, ** p < 0.01 compared with the model group.
Figure 4
Figure 4
DAPI staining and fluorescence observation of L-02 cells.
Figure 5
Figure 5
Molecular docking between anserine and Keap1 and the expressions of Nrf2, HO-1, and NQO1 in L-02 cells. (A) The proposed docking mode of anserine binding with the Keap1 Kelch domain. (B) The binding modes of anserine with Keap1 Kelch domain showing interacting amino acids and H-bonds. (CF) The expressions of Nrf2, HO-1, and NQO1 in L-02 cells. Data are displayed as mean ± SD (n = 6). ## p < 0.01 compared with the control group; * p < 0.05, ** p < 0.01 compared with the model group.
Figure 6
Figure 6
Delaying effect of anserine on the apoptosis of L-02 Cells. (A) Observations using a flow cytometer. (B) Number of apoptotic cells.
Figure 7
Figure 7
The expressions of JNK, p-JNK, BCL-2, Bax, and Cas-3 in L-02 cells. (A) Western blot bands of JNK, p-JNK, BCL-2, Bax, and Cas-3. (BD) Quantitative analysis of p-JNK/JNK, Bcl-2/Bax, and Cas-3. Data are displayed as mean ± SD (n = 3). ## p < 0.01 compared with the control group; * p < 0.05, ** p < 0.01 compared with the model group.

Similar articles

Cited by

References

    1. Forman H.J., Zhang H. Author Correction: Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021;20:652. doi: 10.1038/s41573-021-00267-5. - DOI - PMC - PubMed
    1. Batty M., Bennett M.R., Yu E. The Role of Oxidative Stress in Atherosclerosis. Cells. 2022;11:3843. doi: 10.3390/cells11233843. - DOI - PMC - PubMed
    1. Liu M., Dudley S.C., Jr. Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease. Antioxidants. 2020;9:907. doi: 10.3390/antiox9100907. - DOI - PMC - PubMed
    1. Yaribeygi H., Sathyapalan T., Atkin S.L., Sahebkar A. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxidative Med. Cell. Longev. 2020;2020:8609213. doi: 10.1155/2020/8609213. - DOI - PMC - PubMed
    1. Chen Q.M. Nrf2 for cardiac protection: Pharmacological options against oxidative stress. Trends Pharmacol. Sci. 2021;42:729–744. doi: 10.1016/j.tips.2021.06.005. - DOI - PMC - PubMed